Ana Sekulic

Dr. Ana Sekulic

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
ASAna Sekulic
Ana Sekulic
OMOlivera Marinkovic
Olivera Marinkovic
NNNovica Nikolic
Novica Nikolic
MBMilica Brajkovic
Milica Brajkovic
Barbara LobodaBarbara Loboda
Barbara Loboda
DZDarko Zdravkovic
Darko Zdravkovic
Background/Objectives: Acute Pancreatitis (AP) is an unpredictable inflammatory disease associated with high morbidity and significant mortality, particularly in severe forms. Early death is primarily linked to Systemic Inflammatory Response Syndrome (SIRS) and Multi-Organ Failure (MOF). The objective of this study was to identify objective clinical and laboratory predictors of early and one-year mortality in AP patients and to evaluate the prognostic accuracy of commonly used severity scoring systems. Methods: This prospective, observational study enrolled 50 adult patients admitted to the Intensive Care Unit (ICU) at the University Hospital Center Bežaniska Kosa. Patients with chronic pancreatitis, trauma-induced AP, or late presentation were excluded. Severity scores (APACHE II, BISAP, Ranson, Pancreas) and biomarkers (C-reactive protein, Procalcitonin) were collected at admission (0 h) and dynamically at 48 h, 72 h and day 7. Endpoints were early (in-hospital) and one-year mortality. Results: Overall mortality was 16% (n = 8). Mortality was significantly associated with sepsis/septic shock (p < 0.001), severe AP (p = 0.001), prolonged mechanical ventilation, and ICU stay. At admission, APACHE II (AUROC 0.813) and BISAP (AUROC 0.807) showed good accuracy. Reassessment at 48 h markedly improved prediction: APACHE II achieved excellent value (AUROC 0.917), and the Ranson score became a strong predictor (p < 0.001). Procalcitonin (PCT) was identified as a significant and superior predictor of mortality from 48 h onwards (p < 0.001), outperforming CRP. One-year survival was significantly shorter among patients with sepsis, septic shock, severe AP, and prolonged ICU stay. Conclusions: Dynamic assessment using clinical scoring systems, particularly APACHE II and BISAP within the first 48 h, provides reliable mortality prediction in acute pancreatitis. The presence of sepsis, severe disease, and the need for prolonged organ support are key mortality determinants. Serial PCT monitoring offers sensitive, incremental value for risk stratification and guiding intensive care decisions in both short- and long-term outcomes.

1 January 2026 in Medicinska istrazivanja
Verified
Journal Article
Open access
ASAna Sekulic
Ana Sekulic
OMOlivera Marinković
Olivera Marinković
DMDanilo Milić
Danilo Milić
Background: Perioperative acute kidney injury (AKI) is a serious complication after major non-cardiac surgery, associated with increased mortality, prolonged ICU stay, and the need for renal replacement therapy (RRT). Objective: To assess the impact of AKI severity and associated risk factors on clinical outcomes after major abdominal surgery and to evaluate the prognostic performance of SPARK, APACHE II, and SOFA scores, including sepsis-associated AKI. Materials and Methods: This prospective cohort study was conducted in the Surgical ICU of University Hospital Center "Bežanijska Kosa" (Belgrade) from January to June 2024. Thirty adult patients who developed perioperative AKI after major abdominal surgery were analyzed. AKI was defined according to KDIGO criteria, and sepsis according to Sepsis-3. Disease severity was assessed using APACHE II and SOFA scores, and preoperative AKI risk was assessed using the SPARK index. Results: AKI occurred in 30 operated patients. KDIGO stages were: stage 1 in 26.7%, stage 2 in 30.0%, and stage 3 in 43.3%. In-hospital mortality was 30.0% and occurred exclusively in patients older than 60 years. Mortality was significantly higher in KDIGO stage 3 (61.5% vs. 5.9%, p=0.0016). KDIGO stage 3 and age >60 years were strongly associated with death. SPARK showed good discrimination for severe AKI (AUC≈0.78), while APACHE II demonstrated excellent performance for severe AKI and mortality (AUC≈0.97). RRT use was more frequent in advanced AKI stages. Conclusions: Perioperative AKI was infrequent but severe, with high mortality driven by KDIGO stage 3 and advanced age. SPARK and particularly APACHE II were useful for risk stratification.

8 December 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
ASAna Sekulic
Ana Sekulic
OMOlivera Marinkovic
Olivera Marinkovic
NNNovica Nikolic
Novica Nikolic
MBMilica Brajkovic
Milica Brajkovic
Barbara LobodaBarbara Loboda
Barbara Loboda
DZDarko Zdravkovic
Darko Zdravkovic
Background/Objectives: Acute Pancreatitis (AP) is an unpredictable inflammatory disease associated with high morbidity and significant mortality, particularly in severe forms. Early death is primarily linked to Systemic Inflammatory Response Syndrome (SIRS) and Multi-Organ Failure (MOF). The objective of this study was to identify objective clinical and laboratory predictors of early and one-year mortality in AP patients and to evaluate the prognostic accuracy of commonly used severity scoring systems. Methods: This prospective, observational study enrolled 50 adult patients admitted to the Intensive Care Unit (ICU) at the University Hospital Center Bežaniska Kosa. Patients with chronic pancreatitis, trauma-induced AP, or late presentation were excluded. Severity scores (APACHE II, BISAP, Ranson, Pancreas) and biomarkers (C-reactive protein, Procalcitonin) were collected at admission (0h) and dynamically at 48-72h and day 7. Endpoints were early (in-hospital) and one-year mortality. Results: Overall mortality was 16% (n=8). Mortality was significantly associated with sepsis/septic shock (p<0.001), severe AP ($p=0.001$), prolonged mechanical ventilation, and ICU stay. At admission, APACHE II (AUROC 0.813) and BISAP (AUROC 0.807) showed good accuracy. Reassessment at 48 hours markedly improved prediction: APACHE II achieved excellent value (AUROC 0.917), and the Ranson score became a strong predictor (p<0.001). Procalcitonin (PCT) was identified as a significant and superior predictor of mortality from 48 hours onwards (p<0.001), outperforming CRP. One-year survival was significantly shorter among patients with sepsis, septic shock, severe AP, and prolonged ICU stay. Conclusions: Dynamic assessment using clinical scoring systems, particularly APACHE II and BISAP within the first 48 hours, provides reliable mortality prediction in acute pancreatitis. The presence of sepsis, severe disease, and the need for prolonged organ support are key mortality determinants. Serial PCT monitoring offers sensitive, incremental value for risk stratification and guiding intensive care decisions in both short- and long-term outcomes.

1 January 2026 in Srpski arhiv za celokupno lekarstvo
Verified
Journal Article
Open access
PDF file
BVBojana Vidovic
Bojana Vidovic
ASAna Sekulic
Ana Sekulic
SPSanja Vignjevic Petrinovic
Sanja Vignjevic Petrinovic
NCNatasa Dusan Colakovic
Natasa Dusan Colakovic
SPSimona Petricevic
Simona Petricevic
DZDarko Zdravkovic
Darko Zdravkovic
Introduction/Objective. Subclinical inflammation is increasingly recognized as a driver of postoperative pain, yet its role in breast tumour surgery is not fully defined. The objective was to determine whether preoperative C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR) predict acute postoperative pain (APSP); to examine how surgical extent influences the peri-operative inflammatory response; and to explore the relation between intra-operative fentanyl and pain intensity. Methods. In a prospective single-centre cohort, 101 adults scheduled for breast surgery were stratified into four groups: mastectomy (M, n = 25), tumourectomy (T, n = 28), tumourectomy plus axillary dissection (T+A, n = 20), and benign excision (C, n = 28). Venous blood was drawn on admission (T0) and at 24 h (T24) for CRP and ESR. Pain was assessed with an 11-point Numerical Rating Scale 30 min after recovery and at 24 h; the highest 24-h score (max-APSP) was the primary pain outcome. Results. Pre-operative CRP correlated with max-APSP (p = 0.043), whereas ESR did not (p = 0.11). Baseline CRP and ESR, and their 24-h increments, rose stepwise with surgical magnitude, peaking after mastectomy (baseline CRP 7.1 ± 1.9 mg/L; T24 27.5 ± 3.6 mg•L/¹; both p < 0.01 vs. other groups). Intra-operative fentanyl correlated with CRP at 24 h (r = 0.33, p = 0.001) and with max-APSP (r = 0.28, p = 0.005). Despite these biological gradients, mean max-APSP remained mild to moderate across groups. Conclusion. Pre-surgical systemic inflammation, reflected by CRP, independently predicts early pain after breast tumour surgery. Surgical magnitude amplifies inflammatory markers, and greater fentanyl exposure parallels both inflammation and pain. Routine perioperative CRP may help identify high-risk patients for targeted anti-inflammatory and opioid-sparing analgesic strategies to reduce acute pain and potentially mitigate chronic pain development.